These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 19952991)

  • 41. Comparison of before versus after intravitreal bevacizumab injection, growth factor levels and fibrotic markers in vitreous samples from patients with proliferative diabetic retinopathy.
    Ozer F; Tokuc EO; Albayrak MGB; Akpinar G; Kasap M; Karabas VL
    Graefes Arch Clin Exp Ophthalmol; 2022 Jun; 260(6):1899-1906. PubMed ID: 35028761
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RANDOMIZED CONTROLLED STUDY OF INTRAVITREAL BEVACIZUMAB 0.16 MG INJECTED ONE DAY BEFORE SURGERY FOR PROLIFERATIVE DIABETIC RETINOPATHY.
    Manabe A; Shimada H; Hattori T; Nakashizuka H; Yuzawa M
    Retina; 2015 Sep; 35(9):1800-7. PubMed ID: 25932549
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of intravitreal bevacizumab on vascular endothelial growth factor expression in patients with proliferative diabetic retinopathy.
    Chung EJ; Kang SJ; Koo JS; Choi YJ; Grossniklaus HE; Koh HJ
    Yonsei Med J; 2011 Jan; 52(1):151-7. PubMed ID: 21155048
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intravitreal bevacizumab injection for recurrent vitreous haemorrhage after diabetic vitrectomy.
    Yeh PT; Yang CH; Yang CM
    Acta Ophthalmol; 2011 Nov; 89(7):634-40. PubMed ID: 20064118
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy.
    Modarres M; Nazari H; Falavarjani KG; Naseripour M; Hashemi M; Parvaresh MM
    Eur J Ophthalmol; 2009; 19(5):848-52. PubMed ID: 19787608
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiofibrotic response to vascular endothelial growth factor inhibition in diabetic retinal detachment: report no. 1.
    Sohn EH; He S; Kim LA; Salehi-Had H; Javaheri M; Spee C; Dustin L; Hinton DR; Eliott D
    Arch Ophthalmol; 2012 Sep; 130(9):1127-34. PubMed ID: 22965588
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
    Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
    Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preoperative injection of intravitreal bevacizumab in dense diabetic vitreous hemorrhage.
    Farahvash MS; Majidi AR; Roohipoor R; Ghassemi F
    Retina; 2011; 31(7):1254-60. PubMed ID: 21499192
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Combined pharmacosurgery as treatment for diabetic macular edema: core pars plana vitrectomy and intravitreal injection of bevacizumab and triamcinolone].
    Naser H; Koss MJ; Singh P; Koch F
    Klin Monbl Augenheilkd; 2011 Oct; 228(10):910-4. PubMed ID: 21997827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab.
    Peters S; Heiduschka P; Julien S; Ziemssen F; Fietz H; Bartz-Schmidt KU; ; Schraermeyer U
    Am J Ophthalmol; 2007 Jun; 143(6):995-1002. PubMed ID: 17449002
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Use of bevacizumab in the treatment of complicated proliferative diabetic retinopathy].
    Benhmidoune L; McHachi A; Boukhrissa M; Chakib A; Rachid R; Elbelhadji M; Amraoui A
    J Fr Ophtalmol; 2013 Nov; 36(9):758-63. PubMed ID: 23830522
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravitreal bevacizumab (Avastin) for proliferative diabetic retinopathy: 6-months follow-up.
    Arevalo JF; Wu L; Sanchez JG; Maia M; Saravia MJ; Fernandez CF; Evans T
    Eye (Lond); 2009 Jan; 23(1):117-23. PubMed ID: 17891058
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decreased prothrombin time after intravitreal bevacizumab in the early period in patients with proliferative diabetic retinopathy.
    Qian J; Jiang YR
    Acta Ophthalmol; 2011 Jun; 89(4):e332-5. PubMed ID: 21470390
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR).
    Rizzo S; Genovesi-Ebert F; Di Bartolo E; Vento A; Miniaci S; Williams G
    Graefes Arch Clin Exp Ophthalmol; 2008 Jun; 246(6):837-42. PubMed ID: 18286296
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optical coherence tomography and vessel diameter changes after intravitreal bevacizumab in diabetic macular oedema.
    Soliman W; Vinten M; Sander B; Soliman KA; Yehya S; Rahman MS; Larsen M
    Acta Ophthalmol; 2008 Jun; 86(4):365-71. PubMed ID: 18028237
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduction in dose of intravitreous bevacizumab before vitrectomy for proliferative diabetic retinopathy.
    Yamaji H; Shiraga F; Shiragami C; Nomoto H; Fujita T; Fukuda K
    Arch Ophthalmol; 2011 Jan; 129(1):106-7. PubMed ID: 21220639
    [No Abstract]   [Full Text] [Related]  

  • 57. Bevacizumab (Avastin) for diabetic macular edema in previously vitrectomized eyes.
    Yanyali A; Aytug B; Horozoglu F; Nohutcu AF
    Am J Ophthalmol; 2007 Jul; 144(1):124-6. PubMed ID: 17601433
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema.
    Soheilian M; Ramezani A; Bijanzadeh B; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Tabatabaei H; Peyman GA
    Retina; 2007; 27(9):1187-95. PubMed ID: 18046223
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intravitreal anti-vascular endothelial growth factor therapy with bevacizumab for tuberous sclerosis with macular oedema.
    Saito W; Kase S; Ohgami K; Mori S; Ohno S
    Acta Ophthalmol; 2010 May; 88(3):377-80. PubMed ID: 18778334
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early vitreoretinal surgery on vascularly active stage 4 retinopathy of prematurity through the preoperative intravitreal bevacizumab injection.
    Xu Y; Zhang Q; Kang X; Zhu Y; Li J; Chen Y; Zhao P
    Acta Ophthalmol; 2013 Jun; 91(4):e304-10. PubMed ID: 23647944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.